{
  "created_at": "Tue Jan 25 13:7:11 +0000 2022",
  "id_str": "1485942036205383683",
  "full_text": "Pfizer has begun testing a vaccine that targets the Omicron variant. Initial study results are expected in the first half of the year. https://t.co/Rm6ribIl75",
  "display_text_range": [
    0,
    158
  ],
  "entities": {
    "hashtags": [],
    "symbols": [],
    "user_mentions": [],
    "urls": [
      {
        "url": "https://t.co/Rm6ribIl75",
        "expanded_url": "https://on.wsj.com/3rOrwU3",
        "display_url": "on.wsj.com/3rOrwU3",
        "indices": [
          135,
          158
        ]
      }
    ]
  },
  "user": {
    "name": "The Wall Street Journal",
    "screen_name": "WSJ",
    "profile_image_url_https": "https://pbs.twimg.com/profile_images/971415515754266624/zCX0q9d5_normal.jpg"
  },
  "retweet_count": 39,
  "favorite_count": 82,
  "possibly_sensitive": false,
  "original_created_at": "Tue Jan 25 11:46:03 +0000 2022",
  "localize": [
    {
      "locale": "ja",
      "full_text": "ファイザー社はオミクロン変異体を標的としたワクチンの試験を開始しました。最初の試験結果は今年の前半に期待される。https://t.co/Rm6ribIl75"
    },
    {
      "locale": "zh",
      "full_text": "辉瑞公司已经开始测试一种针对Omicron变体的疫苗。初步研究结果预计将在今年上半年公布。https://t.co/Rm6ribIl75"
    },
    {
      "locale": "zh-Hant",
      "full_text": "輝瑞公司已經開始測試一種針對Omicron變體的疫苗。初步研究結果預計將在今年上半年公佈。https://t.co/Rm6ribIl75"
    }
  ]
}